Skip to main content
. 2017 Mar 13;8(18):30369–30382. doi: 10.18632/oncotarget.16153

Figure 3. Cellular uptake of paclitaxel (PTX) (5 nM) from different formulations at different time points (4 and 8 h) in MCF-7/ADR cells (n=3, mean ± SD).

Figure 3